Deirdra Terrell, Ph.D.

dterrell

 

Assistant Professor

Phone: (405) 271-2229, ext 48386
Office: The University of Oklahoma Health Sciences Center
801 Northeast 13th Street, Room 333
Post Office Box 26901
Oklahoma City, Oklahoma 73126-0901
Email: Deirdra-Terrell@ouhsc.edu

EDUCATION AND TRAINING:

  • Ph.D., Epidemiology, University of Oklahoma Health Sciences Center, OKC, OK
  • M.P.H., Epidemiology, University of Oklahoma Health Sciences Center, OKC, OK
  • B.S, Biology, Oklahoma Baptist University, Shawnee, OK

Recent Publications:

  • Terrell DR, Vesely SK, Hovinga JA, L?mmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. American Journal of Hematology 2010;85:844-847.
  • Royer DJ, George JN, Terrell DR. Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. European Journal of Haematology 2010;84:421-249.
  • Wahl PM, Terrell DR, George JN, Rodgers K, Uhl L, Cataland S, Bohn RL. Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thrombosis and Haemostasis 2010;103:1203-1209.
  • Terrell DR, Beebe LA, Vesely SK, Neas BR, Segal JB, George JN. The incidence of immune thrombocytopenic purpura in children and adults: a critical review of published reports. American Journal of Hematology 2010;85:174-180.
  • Kremer Hovinga J, Vesely SK, Terrell DR, L„mmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-1511.
  • Lewis QF, Lanneau MS, Mathias SD, Terrell DR, Vesely SK, George JN. Long-term deficits in health-related quality of life following recovery from thrombotic thrombocytopenic purpura. Transfusion 2009;49:118-124.
  • Nguyen L, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion 2009;49:392-394.
  • Benjamin M, Terrell DR, Vesely SK, Voskuhl GW, Dezube BJ, Kremer Hovinga J, L„mmle B, George JN. Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clinical Infectious Diseases 2009;48:1129-1137.
  • Swisher KK, Terrell DR, Vesely SK, Kremer Hovinga JA, L„mmle B, George JN.ÿ Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenia purpura.ÿ Transfusion 2009;49:873-887.
  • Terrell DR, Beebe LA, George JN, Vesely SK, Mold JW. Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood 2009;113:4126-4127.
  • Guidry JA, George JN, Vesely SK, Kennison SM, Terrell DR. Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. European Journal of Haematology 2009;83:175-182.
  • Kennedy AS, Lewis QF, Scott JG, Kremer Hovinga JA, L„mmle B, Terrell DR, Vesely SK, George JN. Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion 2009;49:1092-1101.
  • Bose P, Hussein KK, Terrell DR, Berger D, Rice L, George JN. Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: A report of two patients. American Journal of Hematology 2009;84:459-461.
  • Guidry JA, Watson S, George JN, Vesely SK, Terrell DR. Addendum to Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. European Journal of Haematology 2009;83:497-498.
  • George JN, Kremer Hovinga JA, Terrell DR, Vesely SK, Lammle B. The Oklahoma thrombotic thrombocytopenic purpura ? hemolytic uremic syndrome registry: the Swiss connection. European Journal of Haematology 2008;80:277-286.
  • Karpac CA, Li X, Terrell DR, Kremer Hovinga JA, Lammle B, Vesely SK, George JN. Sporadic bloody diarrhea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. British Journal of Haematology 2008;141:696-707.
  • George JN, Terrell DR. Novel thrombopoietic agents: a new era for management of patients with thrombocytopenia. Haematologica 2008;93:5-8.
  • Ambadwar P, Duvall D, Wolf N, Terrell DR, Vesely S, George J. Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. Journal of Clinical Apheresis. 2008;23:168-169.
  • George JN, Terrell DR, Swisher KK, Vesely SK. Lessons learned from the Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry. Journal of Clinical Apheresis 2008;23:129-137.

RESEARCH INTERESTS:

  • Health Disparities
  • Clinical trials
  • Platelet disorders: Idiopathic Thrombocytopenic Purpura (ITP) and Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS)
  • Systemic Lupus Erythematosus

CURRENT RESEARCH PROJECTS:

  • Oklahoma Tobacco Research Center, "Barriers and motivators for smoking cessation in patients with systemic lupus erythematosus (SLE)"
  • Research Supplements to Promote Diversity in Health-Related Research, "Generate hypotheses on the overlap of thrombotic thrombocytopenic purpura (TTP) and systemic lupus erythematosus (SLE)"